Ohtsu, A., Baba, H., Sakata, Y., Mitachi, Y., Horikoshi, N., Sugimachi, K., & Taguchi, T. (2000). Phase II study of S-1, a novel oral fluoropyrimidine derivative, in patients with metastatic colorectal carcinoma. Nature Publishing Group.

Ohtsu, A., H. Baba, Y. Sakata, Y. Mitachi, N. Horikoshi, K. Sugimachi, and T. Taguchi. Phase II Study of S-1, a Novel Oral Fluoropyrimidine Derivative, in Patients With Metastatic Colorectal Carcinoma. Nature Publishing Group, 2000.

Ohtsu, A., et al. Phase II Study of S-1, a Novel Oral Fluoropyrimidine Derivative, in Patients With Metastatic Colorectal Carcinoma. Nature Publishing Group, 2000.